Electrophoretic immunoblotting (EIB [Western blotting]), the hain method for verification of human immunodeficiency virus (HIV) serépositivity, needs thorough characterization and standardization. We explored the possibilities -of quantifying immunoglobulin G (IgG) bound to EIB strips both by densitometry of the peroxidase-stained bands and by measurement of radioactivity with labeled anti-HIV IgG. The radioactivity method is inherently more exact but was more cumbersome. However, despite saturation phenomena at high IgG densities, the densitometric method was more convenient and yielded reproducible estimates of the amount of bound IgG. We found it useful primarily for documentation of changes in the relative abundance of antibodies to different HIV proteins from individual patients over time. To explore the potential usefulness of the method, we studied a small set of HIV-seropositive persons. Thé average p24/gp4l color yield ratios and standard deviations in 3 persons with recent seroconversion, 15 healthy subjects, and 6 diseased HIVseropositive persons were 6.6 ± 0.9, 2.3 ± 1.9, and 1.3 ± 0.5, respectively. (e.g., 6, 18, 19, 27) 
A multitude of more or less sensitive human immunodeficiency virus (HIV) antibody detection systems are now in use. So far, the individual features of each systçm have not been assessed in. a systematic manner. However, the consequences of a false result can be devastating. We need an exact HIV serology.
The occurrence of false-positive reactions in the HIV antibody screening tests necessitates àt least one cbnfirmatory test, mainly the electrophoretic immunoblot (EIB [ Western blot]) (9, 10, 17, 21) . The EIB normally yields qualitative information. However, both for quality control and for laying a firmer foundation of our understanding of HIV pathogenesis and epidemiology, it is desirable to establish more precise, preferably quantitative, diagnostic criteria for the EIB. The sometimes divergent HIV serological results (e.g., 6, 18, 19, 27) cpin/p.g. Briefly, 0.5 mCi of Na'25 I-10 ,g (10 ,ul) of IgG-10 ,ul of lactoperoxidase (0.5 mg/ml)-2 ,u1 of hydrogen peroxide (1/20,000) were reacted for 1 min. After the addition of 0.5 ml of 10 mM sodium azide, macromolecules were Reproducibility. Six sera were quantified by densitometry two to six times (average 3.3) over a period of 1.5 months. The relative standard deviation of the color yields for all protein bands (pi7, p24, p31, gp4l, p53-pSS, and p64) was ± 23%.
(ii) Effect of fading. Three EIB strips were developed with the carbazole stain. They were then quantified 3 days after color development and 23 days later. During this period, they were stored in a dark cupboard in a binder. The average loss of color yield was 18% (standard deviation of 4.5% [n = 12] for bands p17, p24, p31, gp41, p53-p55, and p64).
Titrations of radiolabeled anti-HIV IgG from patients. We looked for signs of saturation of binding with IgG prepared from three different anti-HIV-positive sera. As an example, in a log-log plot (Fig. 1) , the binding was close to linear (r = 0.97 to 0.99) for antibodies binding to all proteins within the range 0.1 to 129 ng of IgG per band. In these experiments, p53 and p55 could be separated. The slopes for both anti-p53 and -p64 were less steep than the slopes of the other curves. (Fig. 3A) . This patient is still n~~~h ealthy. Subsequently, we analyzed sera from 3 acutely infected, 15 healthy, and 6 diseased (3 with acquired immunodeficiency syndrome and 3 with lymphadenopathy syn--r-------drome) HIV-seropositive persons by this method (Fig. 3B) . 40
The acutely infected ail had high ratios (average, 6.6; standard deviation, ±0.9), whereas 'the chronically diseased BOUNOiD~g enerally had low ratios (1.3 ± 0.5). Sera Consequences of the differences in titratioh curve for antibodies to different viral proteins. The variable slopes of the reaction curves of eight different anti-HIV-positive patient sera with the major viral antigens seen with both IgG quantification methods proved that the relative' distribution of IgG per HIV protein varies with concentration of serum. Thus, because of the somewhat variable slopes of the titration curves for antibodies to individual HIV proteins, there will always be a degree of ambiguity regarding the relative color yield in each band. To minimize this effect, comparisons between sera should be made at the same dilution and preferably with the same IgG concentration.
The reason for the more horizontal slopes'of the titration curves, both with respect to color yield and nanograms of IgG, for antibodies reactive with thç pol polypeptides p53 and p64 is not evident from the present work. Differences in affinity are the most likely explanation.
Feasibility and desirability of quantitative serology. Traditionally, serology has been performed in a semiquantitative way by titration to limiting dilution. This approach is adequate in many situations. However, if the diagnosis of an infection with far-reaching consequences (like infection with HIIV) is solely dependent upon the demonstration of antibodies to the etiological agent, the development of more precise methods is justified. Research on acquired immunodeficiency syndrome pathogenesis, the exchange of results between laboratories, diagnosis of HIV carriage, and recognition and differentiation of aberrant serological patterns (1, 18, 19, 27) all would benefit from an accurate description of the anti-HIV antibody status. If in the future a protective role of some anti-HIV antibodies is described and they become used therapeutically, quantitative serology will be necessary for supervision of the levels of these antibodies.
The methodology presented here also permits comparisons of sensitivity, based on quantification of bound IgG, among different EIB methods, as well as other direct-binding solidphase immunoassays for HIV antibody.
Clinical usefulness of quantitative EIB. It is now widely accepted that there is a degree of correlation between health status and loss or persistence of certain anti-HIV antibodies in the HIV infected (see below). However, an interesting difference between African and other HIV-1-infected persons in this respect has recently been reported (1). Quantitative EIB is an objective method which is potentially useful for such serological follow-up. We have preferred calculating a ratio of color yields at a fixed concentration in serum, instead of using the absolute values, to diminish the dependence on overall anti-HIV IgG levels and methodological variations. The widely different p24/gp4l ratios we found for healthy seropositive patients could be due to individual tendencies to react with IgG to different HIV proteins, be a prognostic sign, or less likely, be due to methodological variation. Our observations of high p24/gp4l ratios in a few recently infected patients and low ratios in a few patients with HIV-related disease are, however, in accord with previous qualitative or semiquantitativé descriptions (3, 11, 13-15, 20, 26) . Ideally, a long-term prospective study with more patients, regular sampling, and several other indicators of disease progression is needed to establish the clinical validity of quantitative EIB, as well as to point out further possible improvements of the method. That is, however, beyond the scope of the present paper. LITERATURE 
